We are live on ! Find out more
CDIO icon

Cardio Diagnostics
CDIO

14 hedge funds and large institutions have $2.3M invested in Cardio Diagnostics in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

0% more funds holding

Funds holding: 14 → 14 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0.17% less ownership

Funds ownership: 8.07% → 7.9% (-0.17%)

44% less capital invested

Capital invested by funds: $4.12M → $2.3M (-$1.82M)

Holders
14
Holders Change
–
Holders Change %
0%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$44.5K
2
TSS
Two Sigma Securities
New York
+$32.1K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$26.3K
4
UBS Group
UBS Group
Switzerland
+$23.8K
5
Osaic Holdings
Osaic Holdings
Arizona
+$5.01K

Top Sellers

Rank Fund Capital Flow
1
LA
Linden Advisors
New York
-$114K
2
Squarepoint
Squarepoint
New York
-$97.4K
3
Northern Trust
Northern Trust
Illinois
-$37.6K

CDIO Hedge Fund Activity: Q1 2024 in Review

14 of the 6,961 institutional investors tracked by Wall St. Rank reported a position in Cardio Diagnostics (CDIO) for Q1 2024, worth a combined $2.3M — down 44% from $4.12M a quarter earlier.

Fund positioning in CDIO was balanced in Q1 2024: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 1 trimmed.

The largest buyer was State Street, adding an estimated $44.5K. The largest seller was Linden Advisors, exiting entirely with an estimated $114K sold.

  • 14 institutional investors held Cardio Diagnostics (CDIO) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $2.3M of Cardio Diagnostics stock for Q1 2024, down 44% quarter-over-quarter.
  • 2 funds opened new Cardio Diagnostics positions in Q1 2024 and 2 closed out, a net change of 0 holders.
  • The largest Cardio Diagnostics buyer in Q1 2024 was State Street, an estimated $44.5K added.
  • The largest Cardio Diagnostics seller in Q1 2024 was Linden Advisors, an estimated $114K sold.

Based on aggregated 13F filings for Q1 2024.